Ozempic and Moujaro makers are sued over claims their weight-loss drugs permanently paralyzed their stomachs
- The blockbuster drugmakers allegedly failed to warn of stomach paralysis risks
- The lawsuit includes one patient but 400 others have reached out for legal help
- READ MORE: Ozempic effects left women vomiting years after stopping drug
The drug behemoths behind blockbuster obesity medications Mounjro and Ozempic have been sued over claims that they caused stomach paralysis.
Personal injury firm Morgan & Morgan has taken the case on behalf of a 44-year-old Louisiana woman with diabetes who lost weight while taking the drugs, only to suffer later from severe stomach paralysis marked by such violent vomiting that she has lost some teeth and required multiple trips to the hospital.
The suit against Eli Lilly and Novo Nordisk, which make Mounjaro and Ozempic respectively, alleges that the companies failed to warn consumers about the risk of gastroparesis, or paralysis of the stomach.
Paul Pennock, one of the lawyers representing the Louisiana patient, said: ‘It is our opinion that these drugs are causing these problems. We think that the evidence is sufficient for us to be able to prove it or we would not have filed the case, and we intend to file many more in the coming days and weeks.
‘Her problems have been so severe that she’s been to the emergency room multiple times, including last weekend. She’s actually even thrown up so violently that she’s lost teeth.’
The causes of gastroparesis (stomach paralysis) are largely unknown, but it is thought to be a complication of diabetes, which is why many of these patients take Ozempic and its sister drug Wegovy in the first place
Wegovy and Ozempic work by triggering the body to produce a hormone called GLP-1 that is released naturally from the intestines after meals